Serveur d'exploration H2N2

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Le cluster Child - Child, Preschool

Terms

8Child
9Child, Preschool
10Adolescent
7Infant
13Adult
10Middle Aged
5Young Adult
10Aged

Associations

Freq.WeightAssociation
80.943Child - Child, Preschool
80.894Adolescent - Child
70.882Child, Preschool - Infant
100.877Adolescent - Adult
100.877Adult - Middle Aged
80.843Adolescent - Child, Preschool
60.802Child - Infant
80.800Adolescent - Middle Aged
80.784Adult - Child
70.783Child - Middle Aged
80.740Adult - Child, Preschool
70.738Child, Preschool - Middle Aged
60.717Infant - Middle Aged
60.717Adolescent - Infant
50.707Adolescent - Young Adult
80.702Adult - Aged
70.700Aged - Middle Aged
60.671Aged - Child
60.632Aged - Child, Preschool
60.629Adult - Infant
50.620Adult - Young Adult
60.600Adolescent - Aged
50.598Aged - Infant
40.566Middle Aged - Young Adult
30.474Child - Young Adult
30.447Child, Preschool - Young Adult
30.424Aged - Young Adult
20.338Infant - Young Adult

Documents par ordre de pertinence
000009 (2018) Tara M. Babu [États-Unis] ; Ranawaka A P M. Perera ; Joseph T. Wu ; Theresa Fitzgerald [États-Unis] ; Carolyn Nolan [États-Unis] ; Benjamin J. Cowling ; Scott Krauss [États-Unis] ; John J. Treanor [États-Unis] ; Malik PeirisPopulation Serologic Immunity to Human and Avian H2N2 Viruses in the United States and Hong Kong for Pandemic Risk Assessment
000062 (2011) Danuta M. Skowronski [Canada] ; Travis S. Hottes [Canada] ; Janet E. Mcelhaney [Canada] ; Naveed Z. Janjua [Canada] ; Suzana Sabaiduc [Canada] ; Tracy Chan [Canada] ; Beth Gentleman [Canada] ; Dale Purych [Canada] ; Jennifer Gardy [Canada] ; David M. Patrick [Canada] ; Robert C. Brunham [Canada] ; Gaston De Serres [Canada] ; Martin Petric [Canada]Immuno-epidemiologic Correlates of Pandemic H1N1 Surveillance Observations: Higher Antibody and Lower Cell-Mediated Immune Responses with Advanced Age
000020 (2017) Dennis E. Te Beest [Pays-Bas] ; Erwin De Bruin [Pays-Bas] ; Sandra Imholz [Pays-Bas] ; Marion Koopmans [Pays-Bas] ; Michiel Van Boven [Pays-Bas]Heterosubtypic cross-reactivity of HA1 antibodies to influenza A, with emphasis on nonhuman subtypes (H5N1, H7N7, H9N2)
000114 (2005) Rajan Patel [États-Unis] ; Ira M. Longini ; M Elizabeth HalloranFinding optimal vaccination strategies for pandemic influenza using genetic algorithms.
000148 (1998) Lone Simonsen [Géorgie (pays)] ; Matthew J. Clarke [Géorgie (pays)] ; Lawrence B. Schonberger [Géorgie (pays)] ; Nancy H. Arden [Géorgie (pays)] ; Nancy J. Cox [Géorgie (pays)] ; Keiji Fukuda [Géorgie (pays), États-Unis]Pandemic versus Epidemic Influenza Mortality: A Pattern of Changing Age Distribution
000171 (1987) R. E. Hope-Simpson [Royaume-Uni] ; D. B. Golubev [Russie]A new concept of the epidemic process of influenza A virus
000221 (????) Z. Nikolova ; L Ia Zakstel'Skaia ; R. Kotseva ; E V Molibog[Age profile of the antihemagglutinins and antineuraminidase antibodies in type A influenza (author's transl)].
000036 (2014) Gerald Aichinger [Autriche] ; Barbara Grohmann-Izay [Autriche] ; Maikel V. W. Van Der Velden [Autriche] ; Sandor Fritsch [Autriche] ; Manuela Koska [Autriche] ; Daniel Portsmouth [Autriche] ; Mary Kate Hart [États-Unis] ; Wael El-Amin [États-Unis] ; Otfried Kistner [Autriche] ; P. Noel Barrett [Autriche]Phase I/II Randomized Double-Blind Study of the Safety and Immunogenicity of a Nonadjuvanted Vero Cell Culture-Derived Whole-Virus H9N2 Influenza Vaccine in Healthy Adults
000187 (1981) Arnold S. Monto [États-Unis] ; H. F. Maassab [États-Unis]SEROLOGIC RESPONSES TO NONPREVALENT INFLUENZA A VIRUSES DURING INTERCYCLIC PERIODS
000032 (2015) Irina Isakova-Sivak [Russie] ; Marina Stukova [Russie] ; Mariana Erofeeva [Russie] ; Anatoly Naykhin [Russie] ; Svetlana Donina [Russie] ; Galina Petukhova [Russie] ; Victoria Kuznetsova [Russie] ; Irina Kiseleva [Russie] ; Tatiana Smolonogina [Russie] ; Irina Dubrovina [Russie] ; Maria Pisareva [Russie] ; Alexandra Nikiforova [Russie] ; Maureen Power [États-Unis] ; Jorge Flores [États-Unis] ; Larisa Rudenko [Russie]H2N2 live attenuated influenza vaccine is safe and immunogenic for healthy adult volunteers
000152 (1998) A. Natali [Italie] ; E. Pilotti [Italie] ; P. O. Valcavi [Italie] ; C. Chezzi [Italie] ; J. S. Oxford [Royaume-Uni]Natural and ‘ In vitro ’ selected antigenic variants of influenza A virus (H2N2)
000056 (2012) Jens C. Krause [États-Unis] ; Tshidi Tsibane [États-Unis] ; Terrence M. Tumpey [États-Unis] ; Chelsey J. Huffman [États-Unis] ; Randy Albrecht [États-Unis] ; David L. Blum [États-Unis] ; Irene Ramos [États-Unis] ; Ana Fernandez-Sesma [États-Unis] ; Kathryn M. Edwards [États-Unis] ; Adolfo Garcia-Sastre [États-Unis] ; Christopher F. Basler [États-Unis] ; James E. Jr Crowe [États-Unis]Human Monoclonal Antibodies to Pandemic 1957 H2N2 and Pandemic 1968 H3N2 Influenza Viruses
000153 (1997) K. Matsumoto[Prevention and control of influenza infection in the elderly in Japan--special emphasis on high risk group patients].
000169 (1987) N. Masurel [Pays-Bas]Influenza A and B antibody status in Tanzania
000124 (2004) Thomas A. Reichert ; Lone Simonsen ; Ashutosh Sharma ; Scott A. Pardo ; David S. Fedson [France] ; Mark A. MillerInfluenza and the Winter Increase in Mortality in the United States, 1959–1999
000191 (1980) W H Barker ; J P MulloolyInfluenza vaccination of elderly persons. Reduction in pneumonia and influenza hospitalizations and deaths.

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021